Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD.
Kamada Y, Nakahara T, Munekage K, Fujii H, Sawai Y, Doi Y, Ono M, Hyogo H, Sumida Y, Morishita K, Asuka T, Ouchida T, Imai Y, Miyoshi E; Japan Study Group of NAFLD. Kamada Y, et al. Among authors: hyogo h. Hepatol Commun. 2022 Jul;6(7):1527-1536. doi: 10.1002/hep4.1934. Epub 2022 Apr 27. Hepatol Commun. 2022. PMID: 35478356 Free PMC article.
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K, Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: hyogo h. J Gastroenterol. 2011 Feb;46(2):257-68. doi: 10.1007/s00535-010-0305-6. Epub 2010 Sep 15. J Gastroenterol. 2011. PMID: 20842510
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.
Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Yoneda M, et al. Among authors: hyogo h. J Gastroenterol. 2011 Nov;46(11):1300-6. doi: 10.1007/s00535-011-0436-4. Epub 2011 Jul 13. J Gastroenterol. 2011. PMID: 21750883
Recent trend of clinical features in patients with hepatocellular carcinoma.
Nagaoki Y, Hyogo H, Aikata H, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Imamura M, Kawakami Y, Takahashi S, Chayama K. Nagaoki Y, et al. Among authors: hyogo h. Hepatol Res. 2012 Apr;42(4):368-75. doi: 10.1111/j.1872-034X.2011.00929.x. Epub 2011 Dec 13. Hepatol Res. 2012. PMID: 22151896
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: hyogo h. BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2. BMC Gastroenterol. 2012. PMID: 22221544 Free PMC article.
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Kagawa K, Kawakami Y, Honda Y, Nakahara T, Tanaka M, Naeshiro N, Miyaki D, Nagaoki Y, Kawaoka T, Takaki S, Hiramatsu A, Waki K, Hyogo H, Aikata H, Takahashi S, Arihiro K, Sanetou H, Chayama K. Kagawa K, et al. Among authors: hyogo h. Nihon Shokakibyo Gakkai Zasshi. 2012 Aug;109(8):1401-8. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 22863965 Japanese.
185 results